Molecular Devices, which cut its third-quarter revenue outlook by as much as 12 percent last week, may have to reassess certain product lines if the flat sales continue, President and CEO Joseph Keegan told investors at a recent conference.
Keegan, who refused to blame any one product line or the company’s overall sales and marketing force for the revenue shortfall, also said the company would focus on increasing the level of specialization of a sales and marketing team that “might be at capacity.”

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.

A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.

Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.

In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.